Literature DB >> 9224799

Day-night variation of pituitary adenylate cyclase-activating polypeptide (PACAP) level in the rat suprachiasmatic nucleus.

C Fukuhara1, N Suzuki, Y Matsumoto, Y Nakayama, K Aoki, G Tsujimoto, S I Inouye, Y Masuo.   

Abstract

Adenylate cyclase-activating polypeptide (PACAP) is synthesized in the retinal ganglion cells which terminate on vasoactive intestinal polypeptide neurons in the suprachiasmatic nucleus (SCN), the location of circadian clock. To examine whether PACAP exhibits daily variations in the rat SCN, we measured endogenous PACAP contents throughout the day under 12:12 h light-dark or constant dark conditions. PACAP level was low during the light periods, high during the dark periods, and was stable under constant dark conditions. In the periventricular nucleus of the hypothalamus and cerebral cortex, PACAP content did not show any significant variation throughout the day. Our findings suggest that PACAP content in the SCN may be changed by lighting conditions. Thus, PACAP-containing neurons may play certain roles in the entrainment of circadian rhythms.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9224799     DOI: 10.1016/s0304-3940(97)00415-1

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  9 in total

1.  Overexpression of the human VPAC2 receptor in the suprachiasmatic nucleus alters the circadian phenotype of mice.

Authors:  S Shen; C Spratt; W J Sheward; I Kallo; K West; C F Morrison; C W Coen; H M Marston; A J Harmar
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

2.  BIOLOGICAL TIMEKEEPING.

Authors:  Martha U Gillette; Sabra M Abbott
Journal:  Sleep Med Clin       Date:  2009-06-01

3.  Pituitary adenylate cyclase activating peptide phase shifts circadian rhythms in a manner similar to light.

Authors:  M E Harrington; S Hoque; A Hall; D Golombek; S Biello
Journal:  J Neurosci       Date:  1999-08-01       Impact factor: 6.167

4.  Quantitative peptidomics for discovery of circadian-related peptides from the rat suprachiasmatic nucleus.

Authors:  Ji Eun Lee; Leonid Zamdborg; Bruce R Southey; Norman Atkins; Jennifer W Mitchell; Mingxi Li; Martha U Gillette; Neil L Kelleher; Jonathan V Sweedler
Journal:  J Proteome Res       Date:  2013-01-11       Impact factor: 4.466

5.  Pituitary adenylate cyclase-activating polypeptide and melatonin in the suprachiasmatic nucleus: effects on the calcium signal transduction cascade.

Authors:  M D Kopp; C Schomerus; F Dehghani; H W Korf; H Meissl
Journal:  J Neurosci       Date:  1999-01-01       Impact factor: 6.167

6.  CREB in the mouse SCN: a molecular interface coding the phase-adjusting stimuli light, glutamate, PACAP, and melatonin for clockwork access.

Authors:  C von Gall; G E Duffield; M H Hastings; M D Kopp; F Dehghani; H W Korf; J H Stehle
Journal:  J Neurosci       Date:  1998-12-15       Impact factor: 6.167

7.  Effect of transcutaneous cervical vagus nerve stimulation on the pituitary adenylate cyclase-activating polypeptide (PACAP) response to stress: A randomized, sham controlled, double blind pilot study.

Authors:  Nil Z Gurel; Yunshen Jiao; Matthew T Wittbrodt; Yi-An Ko; Allison Hankus; Emily G Driggers; Stacy L Ladd; Lucy Shallenberger; Nancy Murrah; Minxuan Huang; Ammer Haffar; Mhmtjamil Alkhalaf; Oleksiy Levantsevych; Jonathon A Nye; Viola Vaccarino; Amit J Shah; Omer T Inan; J Douglas Bremner; Bradley D Pearce
Journal:  Compr Psychoneuroendocrinol       Date:  2020-10-27

8.  gH625-liposomes deliver PACAP through a dynamic in vitro model of the blood-brain barrier.

Authors:  Teresa Barra; Annarita Falanga; Rosa Bellavita; Vincenza Laforgia; Marina Prisco; Stefania Galdiero; Salvatore Valiante
Journal:  Front Physiol       Date:  2022-08-19       Impact factor: 4.755

9.  Melatonin mediates monochromatic green light-induced satellite cell proliferation and muscle growth in chick embryo.

Authors:  Xinjie Bai; Jing Cao; Yulan Dong; Zixu Wang; Yaoxing Chen
Journal:  PLoS One       Date:  2019-05-06       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.